Observational clinical study on organ dysfunction associated with dosing of antibiotics in a Pediatric Intensive Care

Sascha Tafelski1, Alexander Gratopp2, Florian Richter1

  • 1Department of Anesthesiology and Intensive Care Medicine Campus, Charité Mitte and Campus Virchow-Klinikum, Charité-Universitaetsmedizin Berlin, Berlin, Germany.

Minerva Pediatrica
|November 11, 2016
PubMed

Insights

Incorrect antibiotic dosing in critically ill children significantly increases organ dysfunction and mortality risk. Adhering to weight- and age-based dosing protocols improves outcomes and reduces pediatric intensive care unit (PICU) stays.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Clinical research

Background:

  • Medication errors are a significant concern in pediatric patient care.
  • Antibiotic dosing errors in critically ill children can lead to adverse outcomes.
  • This study focuses on the impact of antibiotic dosing errors on outcomes in pediatric intensive care units (PICUs).

Purpose of the Study:

  • To investigate the impact of antibiotic dosing errors on clinical outcomes in critically ill pediatric patients.
  • To evaluate the association between antibiotic dosage adherence and organ dysfunction.
  • To assess the effect of dosing errors on length of stay and mortality in the PICU.

Main Methods:

  • Retrospective study of pediatric patients admitted to a university PICU in 2010.
  • Evaluation of antibiotic dosages for compliance with weight-, age-, and organ function-adapted recommendations.
  • Primary endpoint: organ dysfunction (liver injury or acute kidney injury); secondary endpoints: PICU stay, ventilation duration, and mortality.

Main Results:

  • 38.6% of antibiotic dosages were incorrect, affecting 130 patients (low-adherence group).
  • The low-adherence group had a 7-fold increased risk of new-onset organ dysfunction.
  • Incorrect dosing was associated with longer PICU stays (7 vs. 3 days), prolonged ventilation (8 vs. 2 days), and increased PICU mortality.

Conclusions:

  • Adherence to bodyweight- and age-adapted antibiotic dosage protocols is crucial.
  • Appropriate dosing is associated with reduced organ dysfunction in pediatric patients.
  • Optimized antibiotic dosing leads to more favorable clinical outcomes in the PICU.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
669
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
441
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
307
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
324